We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01707472
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : December 16, 2015
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Gilead Sciences